article The other end of the antibody: Fc biology and immunotherapy 14 June 2021 | By Dr Björn Frendeus (BioInvent) Dr Björn Frendeus outlines how the growing biology surrounding the inhibitory Fc receptor FcγRIIb defines a target for improving existing and future antibody treatments.